humanized mice model market size, share & forecast 2025
Post on 20-Nov-2020
6 Views
Preview:
DESCRIPTION
TRANSCRIPT
MARKET INTELLIGENCE . CONSULTINGwww.techsciresearch.com
GLOBAL HUMANIZED MICE MODEL MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
2
Scope of ReportProduct of Interest (POI): Humanized Mice Model
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• Rest of World
Global humanized mice model market is projected to grow at a CAGR of more than 10%during 2020 - 2025. The global humanized mice model market is driven by continuousresearch and development activities in pharmaceutical companies across the globe. Inaddition to this, increasing investments for research in laboratories and institutes ispositively impacting the growth of market.
Market SegmentationTYPE
• Cell-line
transplantation model
• Patient based
xenografts
• Genetically Engineered
Mice
• Others
• Breeding
• Model In-Licensing
• Genetic Testing
• Other Services
SERVICE
IMMUNE CHECKPOINTS
• PD-1
• CTLA-4
• CD-39
• Others
• Immuno-Oncology
Studies
• Diabetes Studies
• Cardiovascular Studies
• Central Nervous
System (CNS) Studies
• Other Type Studies
APPLICATION
• Companies
(Pharmaceutical,
BioService)
• Academic and
Research Institutes
• Contract Research
Organizations
END USER
3
Table of Contents
S. No. Contents Page No.
1. Product Overview (Definition of product and major terminologies used in the report)
2.Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on Global Humanized Mice Model Market
4. Executive Summary
5. Voice of Customer
5.1. Factors Influencing Purchase Decision
5.2. Brand Recall
5.3. Challenges/Unmet Needs
6. Global Humanized Mice Model Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service (Breeding, Model In-Licensing, Genetic Testing, Other Services)
6.2.2.By Type (Cell-line transplantation model, Patient based xenografts, Genetically Engineered Mice, Others)
6.2.3.By Application (Immuno-Oncology Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Other Type Studies)
6.2.4. By Immune Checkpoints (PD-1, CTLA-4, CD-39, Others)
6.2.5.By End User (Companies, Academic and Research Institutes, Contract Research Organizations)
6.2.6. By Region (Asia-Pacific, Europe, North America, Rest of the World)
4
Table of Contents
S. No. Contents Page No.
6.2.7. By Company
6.3. Product Market Map
7. Asia-Pacific Humanized Mice Model Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Type
7.2.3. By Application
7.2.4. By Immune Checkpoints
7.2.5. By End User
7.2.6. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Humanized Mice Model Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Type
7.3.1.2.3. By Application
5
Table of Contents
S. No. Contents Page No.
7.3.1.2.4. By End User
7.3.2. India Humanized Mice Model Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Type
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Australia Humanized Mice Model Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Type
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Japan Humanized Mice Model Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
6
Table of Contents
S. No. Contents Page No.
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Type
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. South Korea Humanized Mice Model Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Type
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Europe Humanized Mice Model Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Type
8.2.3. By Application
7
Table of Contents
S. No. Contents Page No.
8.2.4. By Immune Checkpoints
8.2.5. By End User
8.2.6. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Europe: Country Analysis
8.3.1. France Humanized Mice Model Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Type
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. Germany Humanized Mice Model Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Type
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8
Table of Contents
S. No. Contents Page No.
8.3.3. United Kingdom Humanized Mice Model Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Type
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Italy Humanized Mice Model Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Type
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Spain Humanized Mice Model Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
9
Table of Contents
S. No. Contents Page No.
8.3.5.2.1. By Service
8.3.5.2.2. By Type
8.3.5.2.3. By Application
8.3.5.2.4. By End User
8.3.6. Russia Humanized Mice Model Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Service
8.3.6.2.2. By Type
8.3.6.2.3. By Application
8.3.6.2.4. By End User
9. North America Humanized Mice Model Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Type
9.2.3. By Application
9.2.4. By Immune Checkpoints
10
Table of Contents
S. No. Contents Page No.
9.2.5. By End User
9.2.6. By Country (United States, Canada, Mexico)
9.3. North America: Country Analysis
9.3.1. United States Humanized Mice Model Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Type
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Canada Humanized Mice Model Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Type
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Mexico Humanized Mice Model Market Outlook
11
Table of Contents
S. No. Contents Page No.
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Type
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Rest of World Humanized Mice Model Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Type
10.2.3. By Application
10.2.4 By Immune Checkpoints
10.2.5. By End User
10.2.6. By Country (Brazil, South Africa, Israel)
10.3. Rest of World: Country Analysis
10.3.1. Brazil Humanized Mice Model Market Outlook
10.3.1.1. Market Size & Forecast
12
Table of Contents
S. No. Contents Page No.
10.3.1.1.1 By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Type
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. South Africa Humanized Mice Model Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Type
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Israel Humanized Mice Model Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.2.2.2. By Type
13
Table of Contents
S. No. Contents Page No.
11. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
11.1. Drivers
11.2. Challenges
12.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)
13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Company Details
13.2.2. Products & Services
13.2.3. Financials (As Reported)
13.2.4. Key Market Focus and Geographical Presence
13.2.5. Planned Investments
13.2.6. Market Positioning
13.3. Leading Players Profiled
14.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)
15. About Us & Disclaimer
10.3.2.2.3. By Application
10.3.2.2.4. By End User
RESEARCH METHODOLOGY
15
Research Methodology
✓ Identifying Key Opinion
Leaders
✓ Questionnaire Design
✓ In-depth Interviews
Data Collection
Developing List of Respondents
Formulating Questionnaire
Market Profiling
Data Validation
Data Analysis
In-depth secondary research was conducted to
determine top players in the global humanized mice
model market, overall market size and segmental
market size.
In order to conduct industry experts’
interviews, TechSci formulated a detailed
discussion guide.
List of industry players and industry
specialists was developed.
TechSci conducted interviews with
industry experts and industry players for data collection and
verification.
Data obtained as a result of primary and secondary research was
validated through rigorous
triangulation.
The data was scrutinized using MS-Excel, statistical
tools and internal proprietary database to obtain qualitative and
quantitative insights about the global humanized mice
model market.
Data
Collection
Data Filter
& AnalysisResearch &
Intelligence
Actionable
InsightsBusiness
Solution
Primary Research Desk Research Company Analysis
✓ Recent Developments
✓ Market Changing
Aspects/Dynamics
✓ Government Policies
✓ Conclusion
✓ Market Participants
✓ Key Strengths
✓ LinkedIn✓ TechSci Internal
Database
✓ Factiva✓ Hoovers
Paid Sources
✓ Company Websites✓ Company Annual
Reports✓ White Paper Study✓ Financial Reports✓ Investor
Presentations✓ Regulatory Body✓ Associations, etc.
Secondary Research
Primary Research
16
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global humanized mice model market. The team has
analyzed the outlook of various segments of this market, while considering the major influencing factors such as continuous research and development
activities in pharmaceutical companies. The study includes market forecasting, which would enable our clients to take better decisions while planning
their strategy to achieve sustainability in the global humanized mice model market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through exhaustive
secondary research and primary surveys, with various key opinion leaders/stakeholders, such as humanized mice model companies, channel
partners, market influencers & end-users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 humanized mice model companies, 100 – 120 end-users, and 15 – 20 industry experts and other value
chain stakeholders in the global humanized mice model market to obtain the overall market size from 2015 to 2019, which was validated by the
Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-
2019.
17
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by service, by type, by application, by immune
checkpoints, by end user, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise
revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various
segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
Market share by service, by type, by application, by immune checkpoints, by end user, by company and by region were calculated based on the
responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated
from various segments of humanized mice model market. The final shares were calculated by taking the geometric mean of the responses gathered
from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in
SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global humanized
mice model market, TechSci Research used various forecast techniques such as:
✓ Moving Average
✓ Time Series Analysis
✓ Regression Analysis
✓ Econometric and Judgmental Analysis
18
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used
the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that
the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD),
with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
• Charles River Laboratories, International, Inc.
• The Jackson Laboratory
• Gempharmatech Co Ltd
• Taconic Biosciences, Inc.
• Envigo (Harlan Laboratories, Inc.)
• Laboratory Corporation of America Holdings
• Janvier Labs
• Trans Genic, Inc.
• Genoway
• Creative Biolabd
• Horizon Discovery Group
• Ingenious Targeting Laboratory
• Biocytogen
• Taconic Biosciences
• World Bank
• TechSci Research Proprietary Database & Knowledge Repository
• Company Annual Reports
• Industry Magazines
• Industry Reports
• News Dailies
• Credible Paid Databases
19
Industry Brief
According to TechSci Research report, “Global Humanized Mice Model Market By Service, By Type, By Immune Checkpoints, By Application, By
End-user, By Region, Competition, Forecast & Opportunities, 2025”, the global humanized mice model market is projected to grow at a CAGR of
10% during the forecast period on account of expanding pipeline of pharmaceutical and biopharmaceutical companies across the globe. Besides,
growing application of mice model for research purpose such as for immunology and inflammation studies, central nervous system studies,
among others, is further expected to fuel the market growth. Moreover, growing rising demand for mice model in cancer research so that genetic
basis of tumor development and cancer progression can be studied, is further driving the market. However, there are certain factors that might
act as major impediments to the growth of global mice model market during the forecast period such as growing concern for the wellbeing of
animals coupled with increasing awareness pertaining to animal rights.
Based on the application, the market is segmented into immune-oncology, central nervous system, cardiovascular, diabetes and others. The
immune-oncology segment accounted for the largest market share in 2019 and the segment is expected to maintain its market dominance during
the forecast period as well due to the growing rate of cancer cases and increasing investments on immune-oncology research. Based on type,
the market is fragmented into cell line transplantation model, patient derived xenografts, genetically engineered mouse model and others. Out of
these segments, the cell transplantation model segment dominated the market until 2019, genetically engineered mouse model and patient
derived xenografts segments.
Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan
Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd, Horizon Discovery
Group, Ingenious Targeting Laboratory, Biocytogen, Taconic Biosciences are some of the leading players operating in global humanized mice
model market. “North America is expected to dominate the humanized mice model market during the forecast period owing to surging focus on
biomedical research in the region, predominantly in the United States. Additionally, rising demand for monoclonal antibody production is further
expected to spur the market growth.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management
consulting firm.
20
Sample Data - Snapshot
Figure XX: Global Humanized Mice Model Market Size, By Value (USD Million), 2015-2025F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
By Value (USD Million)
CAGR By Value CAGR By Value
XX% YY%
North America Humanized Mice Model Market Share, By Service, By Value, 2015–2025F
25%25%25%25%25%25%25%25%25%25%25%
25%25%25%25%25%25%25%25%25%25%25%
25%25%25%25%25%25%25%25%25%25%25%
25%25%25%25%25%25%25%25%25%25%25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Breeding Model In-Licensing Genetic Testing Other Services
Canada Humanized Mice Model Market Share, By Type, By Value, 2015–2025F
30%30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
30%30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Cell-line transplantation model Patient based xenografts Genetically Engineered Mice Others
21
Report Ordering
Report Name: GLOBAL HUMANIZED MICE MODEL MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
To View Sample OR Purchase Report
License Type Price
Single User License $4450
Multi-User License $5450
Custom Research License $9450
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting
Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and
global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the
market.
Related Reports
• Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product
(Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
• Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management,
Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Type (Disposable and Reusable), By End User
(Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or
complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand.
However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results
obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together
with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal
consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
TechSci Research – North America708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com
top related